PharmaDirections

PharmaDirections

PharmaDirections was founded in 2008 as a virtual drug development partner, serving small, start-up, and micro-biotech companies. The firm counts Michelle Higgin, Bruce Rehlaender, Tilmann Brotz, Murali Duvvuri, Jessica Beaver, and Rick Soltero among its senior experts, though no single founder or principal is publicly identified as the majority owner or operator. Wealth origin of the firm is not disclosed. The firm deploys a virtual team-based model, providing program managers, drug discoverers, CMC and quality managers, preclinical experts, pharmacokinetic modelers, regulatory experts, and intellectual property inventors. It reports managing over $50M in annual outsourced contract work (CRO/CDMO) (per PharmaDirections website, 2025). PharmDirections claims a network of over 200 experts and program managers, and more than 150 partner companies. Its geographic footprint is U.S.-based, with headquarters in Cary, NC, and additional offices in Cambridge, MA, Charlottesville, VA, and RTP, NC. PharmaDirections maintains a core staff of 25+ employees, supported by a larger network of associates. The firm lists hubs in the Pacific Northwest and San Francisco Bay Area. Its website claims 17 years of operation (through 2025), consistent with a 2008 founding. As of 2025, the firm has no publicly disclosed recent operational events. It does not operate stand-alone philanthropic vehicles or adjacent investment arms that are publicly visible. PharmaDirections differs from traditional contract research organizations by taking no equity stake in the intellectual property it helps generate. The firm's model is strictly fee-for-service, billing only for hours applied to milestones. This structure allows it to work across therapeutic areas and modalities without the incentives that come with ownership positions in client companies.